论文部分内容阅读
目的:分析探讨应用活血化瘀药物辅助治疗急性脑出血患者的临床疗效。方法:选取2012年1月至2014年1月该院收治的急性脑出血患者80例,随机分为实验组和对照组,对照组患者采用常规西医进行治疗,实验组患者在对照组的基础上采用活血化瘀药物进行辅助治疗,比较两组患者临床疗效。结果:实验组患者总有效率为85.4%,死亡率为4.9%;对照组患者总有效率为74.4%,死亡率为12.8%;两组比较差异显著(P<0.05)。结论:应用中医活血化瘀药物辅助治疗急性脑出血具有较高疗效,可有效改善患者生存治疗,降低患者死亡率,临床意义突出,值得推广和使用。
Objective: To analyze and discuss the clinical curative effect of adjuvant therapy of activating blood and resolving stasis in patients with acute cerebral hemorrhage. Methods: A total of 80 acute cerebral hemorrhage patients admitted to our hospital from January 2012 to January 2014 were randomly divided into experimental group and control group. Patients in the control group were treated with routine western medicine. On the basis of the control group, Adopting blood-activating and stasis-removing drugs for adjuvant therapy and comparing the clinical curative effect of the two groups. Results: The total effective rate was 85.4% and the mortality rate was 4.9% in the experimental group. The total effective rate was 74.4% and the mortality rate was 12.8% in the control group. The difference between the two groups was significant (P <0.05). Conclusion: The application of traditional Chinese medicine promoting blood circulation and removing blood stasis drugs in the treatment of acute cerebral hemorrhage has a higher curative effect, which can effectively improve patients’ survival treatment and reduce the mortality of patients with outstanding clinical significance, which is worthy of promotion and use.